Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-10-29 08:00 |
Valneva annonce la suspension temporaire du cours de ses actions ordinaires sur…
|
French | 129.0 KB | ||
| 2021-10-29 08:00 |
Valneva announces temporary trading suspension of its ordinary shares on Eurone…
|
English | 132.0 KB | ||
| 2021-10-29 07:00 |
Valneva annonce la fixation du prix de ses titres pour son Offre Globale d’Amer…
|
French | 351.2 KB | ||
| 2021-10-29 07:00 |
Valneva Announces the Pricing of its Global Offering of American Depositary Sha…
|
English | 181.6 KB | ||
| 2021-10-27 01:22 |
Valneva Publishes Amendment to 2020 Universal Registration Document
|
English | 439.0 KB | ||
| 2021-10-27 01:22 |
Valneva publie un amendement à son Document d’enregistrement universel 2020
|
French | 410.2 KB | ||
| 2021-10-27 00:44 |
Valneva annonce le lancement d’un projet d’offre globale d’American Depositary …
|
French | 431.5 KB | ||
| 2021-10-18 07:00 |
Valneva Reports Positive Phase 3 Results for Inactivated, Adjuvanted COVID-19 V…
|
English | 380.3 KB | ||
| 2021-10-18 07:00 |
Valneva annonce des résultats de Phase 3 positifs pour son candidat vaccin inac…
|
French | 475.3 KB | ||
| 2021-10-05 18:05 |
Déclaration d’actions et de droits de vote - Situation intermédiaire au 4 octob…
|
French | 164.4 KB | ||
| 2021-10-04 19:00 |
Valneva annonce l’annulation des actions ordinaires auto-détenues par la Sociét…
|
French | 210.9 KB | ||
| 2021-10-04 19:00 |
Valneva Announces the Cancellation of Ordinary Shares Held by the Company follo…
|
English | 129.3 KB | ||
| 2021-09-30 17:45 |
Valneva to Present and Hold Investor Meetings at the Guggenheim Vaccines and In…
|
English | 129.6 KB | ||
| 2021-09-30 17:45 |
Valneva présentera et participera à des réunions investisseurs lors de la confé…
|
French | 130.2 KB | ||
| 2021-09-28 07:00 |
Valneva et Pfizer annoncent de nouveaux résultats positifs de Phase 2, incluant…
|
French | 835.2 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
